We have located links that may give you full text access.
The association of coagulopathy with liver dysfunction in patients with COVID-19.
AIM: Liver dysfunction is sometimes observed in patients with coronavirus disease 2019 (COVID-19), but most of studies are from China and the frequency in other countries is unclear. In addition, previous studies suggested several mechanisms of liver damage but precise or additional mechanisms are not clearly elucidated. Therefore, we examined COVID-19 patients to explore the proportion of patients with liver dysfunction and also the factors associated with liver dysfunction.
METHODS: We retrospectively examined sixty COVID-19 patients hospitalized in our hospital. Patients who presented 40 or higher levels of alanine aminotransferase (ALT) at least once during the hospitalization were defined as high-ALT patients, and the others as normal-ALT patients. The worst values of physical and laboratory findings during the hospitalization in each case were extracted for the analyses. Univariable and multivariable logistic regression models with bootstrap (for 1000 times) were conducted.
RESULTS: Among 60 patients, there were thirty-one (52%) high-ALT patients. The high-ALT patients were obese and had significantly higher levels of D-dimer and fibrin/fibrinogen degradation products as well as white blood cell (WBC) count and levels of C-reactive protein, ferritin, and fibrinogen. Multivariable analysis revealed D-dimer and WBC as independent factors.
CONCLUSION: Considering that higher D-dimer level and WBC count were independently associated with ALT elevation, liver dysfunction in COVID-19 patients might be induced by microvascular thrombosis in addition to systemic inflammation.
METHODS: We retrospectively examined sixty COVID-19 patients hospitalized in our hospital. Patients who presented 40 or higher levels of alanine aminotransferase (ALT) at least once during the hospitalization were defined as high-ALT patients, and the others as normal-ALT patients. The worst values of physical and laboratory findings during the hospitalization in each case were extracted for the analyses. Univariable and multivariable logistic regression models with bootstrap (for 1000 times) were conducted.
RESULTS: Among 60 patients, there were thirty-one (52%) high-ALT patients. The high-ALT patients were obese and had significantly higher levels of D-dimer and fibrin/fibrinogen degradation products as well as white blood cell (WBC) count and levels of C-reactive protein, ferritin, and fibrinogen. Multivariable analysis revealed D-dimer and WBC as independent factors.
CONCLUSION: Considering that higher D-dimer level and WBC count were independently associated with ALT elevation, liver dysfunction in COVID-19 patients might be induced by microvascular thrombosis in addition to systemic inflammation.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
The Effect of Albumin Administration in Critically Ill Patients: A Retrospective Single-Center Analysis.Critical Care Medicine 2024 Februrary 8
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app